Integrin β3 Inhibitors

Common Integrin β3 Inhibitors include, but are not limited to Lovastatin CAS 75330-75-5, Curcumin CAS 458-37-7, Resveratrol CAS 501-36-0, (-)-Epigallocatechin Gallate CAS 989-51-5 and Genistein CAS 446-72-0.

Integrins represent a large family of heterodimeric cell surface receptors involved in mediating cell-cell and cell-extracellular matrix (ECM) interactions. These receptors are composed of non-covalently associated α and β subunits, with each subunit containing a large extracellular domain, a single transmembrane segment, and a short cytoplasmic tail. One of the key members of this family is the Integrin β3 subunit. When paired with the αv subunit, it forms the αvβ3 integrin, and when paired with the αIIb subunit, it forms the αIIbβ3 integrin. These specific integrin combinations are involved in various cellular processes, including adhesion, signaling, and migration.

Integrin β3 inhibitors are molecules specifically designed to target and modulate the activity of integrins containing the β3 subunit. Their mode of action primarily involves hindering the binding interactions between the integrin and its natural ligands in the ECM, such as fibronectin, vitronectin, and fibrinogen. By preventing these interactions, Integrin β3 inhibitors can disrupt the downstream signaling events and cellular responses mediated by these integrins.